Equities

Bayer AG

Bayer AG

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (EUR)102.34
  • Today's Change-2.70 / -2.57%
  • Shares traded1.45m
  • 1 Year change-13.31%
  • Beta1.0299
Data delayed at least 15 minutes, as of May 23 2018 13:29 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

As of May 18, 2018, the consensus forecast amongst 30 polled investment analysts covering Bayer AG advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Feb 06, 2006. The previous consensus forecast advised investors to hold their position in Bayer AG.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy11
Outperform5
Hold13
Underperform0
Sell0

Share price forecast

The 26 analysts offering 12 month price targets for Bayer AG have a median target of 119.50, with a high estimate of 140.00 and a low estimate of 94.00. The median estimate represents a 13.77% increase from the last price of 105.04.
High33.3%140.00
Med13.8%119.50
Low-10.5%94.00

Dividends

Dividend information is not available for Bayer AG.
Div growth (TTM)3.70%
More ▼

Earnings history & estimates

On May 03, 2018, Bayer AG reported 1st quarter 2018 earnings of 2.28 per share. This result exceeded the 2.07 consensus of the 10 analysts covering the company and under-performed last year's 1st quarter results by 12.98%.
The next earnings announcement is expected on Sep 05, 2018.
Average growth rate+1.98%
Bayer AG reported annual 2017 earnings of 6.74 per share on Feb 28, 2018.
The next earnings announcement from Bayer AG is expected the week of Feb 27, 2019.
Average growth rate+5.00%
More ▼

Revenue history & estimates

Bayer Aktiengesellschaft had 1st quarter 2018 revenues of 9.14bn. This missed the 9.39bn consensus estimate of the 11 analysts following the company. This was 31.00% below the prior year's 1st quarter results.
Average growth rate-7.17%
Bayer Aktiengesellschaft had revenues for the full year 2017 of 35.02bn. This was 25.13% below the prior year's results.
Average growth rate-2.33%
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.